nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—ALB—stomach cancer	0.238	1	CbGaD
Enzalutamide—ABCB1—Mitomycin—stomach cancer	0.0915	0.169	CbGbCtD
Enzalutamide—CYP2B6—Irinotecan—stomach cancer	0.0458	0.0844	CbGbCtD
Enzalutamide—ALB—Irinotecan—stomach cancer	0.0449	0.0828	CbGbCtD
Enzalutamide—ALB—Fluorouracil—stomach cancer	0.0431	0.0794	CbGbCtD
Enzalutamide—CYP2C9—Capecitabine—stomach cancer	0.0391	0.0722	CbGbCtD
Enzalutamide—CYP3A5—Irinotecan—stomach cancer	0.0361	0.0665	CbGbCtD
Enzalutamide—CYP2C8—Fluorouracil—stomach cancer	0.0333	0.0614	CbGbCtD
Enzalutamide—CYP3A5—Docetaxel—stomach cancer	0.0264	0.0487	CbGbCtD
Enzalutamide—CYP2B6—Doxorubicin—stomach cancer	0.025	0.0461	CbGbCtD
Enzalutamide—ALB—Methotrexate—stomach cancer	0.0237	0.0438	CbGbCtD
Enzalutamide—ABCB1—Irinotecan—stomach cancer	0.0235	0.0433	CbGbCtD
Enzalutamide—CYP2C9—Fluorouracil—stomach cancer	0.0232	0.0428	CbGbCtD
Enzalutamide—ABCB1—Docetaxel—stomach cancer	0.0172	0.0317	CbGbCtD
Enzalutamide—CYP3A4—Irinotecan—stomach cancer	0.0141	0.0259	CbGbCtD
Enzalutamide—ABCB1—Doxorubicin—stomach cancer	0.0128	0.0237	CbGbCtD
Enzalutamide—ABCB1—Methotrexate—stomach cancer	0.0124	0.0229	CbGbCtD
Enzalutamide—CYP2D6—Doxorubicin—stomach cancer	0.0121	0.0223	CbGbCtD
Enzalutamide—CYP3A4—Docetaxel—stomach cancer	0.0103	0.019	CbGbCtD
Enzalutamide—CYP3A4—Doxorubicin—stomach cancer	0.00768	0.0142	CbGbCtD
Enzalutamide—ALB—gall bladder—stomach cancer	0.00162	0.077	CbGeAlD
Enzalutamide—AR—hematopoietic system—stomach cancer	0.000795	0.0379	CbGeAlD
Enzalutamide—CYP2C19—hematopoietic system—stomach cancer	0.000737	0.0351	CbGeAlD
Enzalutamide—AR—epithelium—stomach cancer	0.000727	0.0346	CbGeAlD
Enzalutamide—AR—smooth muscle tissue—stomach cancer	0.000701	0.0334	CbGeAlD
Enzalutamide—CYP2C8—hematopoietic system—stomach cancer	0.000643	0.0306	CbGeAlD
Enzalutamide—Hot flush—Docetaxel—stomach cancer	0.000622	0.00502	CcSEcCtD
Enzalutamide—Infestation—Fluorouracil—stomach cancer	0.000621	0.00501	CcSEcCtD
Enzalutamide—Infestation NOS—Fluorouracil—stomach cancer	0.000621	0.00501	CcSEcCtD
Enzalutamide—Menopausal symptoms—Docetaxel—stomach cancer	0.000617	0.00498	CcSEcCtD
Enzalutamide—Hot flush—Capecitabine—stomach cancer	0.000602	0.00486	CcSEcCtD
Enzalutamide—Amnesia—Capecitabine—stomach cancer	0.0006	0.00484	CcSEcCtD
Enzalutamide—Menopausal symptoms—Capecitabine—stomach cancer	0.000597	0.00482	CcSEcCtD
Enzalutamide—Headache—Mitomycin—stomach cancer	0.000597	0.00481	CcSEcCtD
Enzalutamide—Epistaxis—Fluorouracil—stomach cancer	0.000586	0.00473	CcSEcCtD
Enzalutamide—Rhinitis—Irinotecan—stomach cancer	0.000584	0.00471	CcSEcCtD
Enzalutamide—Sinusitis—Fluorouracil—stomach cancer	0.000583	0.0047	CcSEcCtD
Enzalutamide—CYP3A5—hematopoietic system—stomach cancer	0.000581	0.0276	CbGeAlD
Enzalutamide—ABCB1—blood vessel—stomach cancer	0.000579	0.0276	CbGeAlD
Enzalutamide—CYP2B6—hematopoietic system—stomach cancer	0.000577	0.0275	CbGeAlD
Enzalutamide—Connective tissue disorder—Irinotecan—stomach cancer	0.000572	0.00462	CcSEcCtD
Enzalutamide—CYP2C9—hematopoietic system—stomach cancer	0.000571	0.0272	CbGeAlD
Enzalutamide—AR—lymphoid tissue—stomach cancer	0.00056	0.0267	CbGeAlD
Enzalutamide—Rhinitis—Fluorouracil—stomach cancer	0.000559	0.00451	CcSEcCtD
Enzalutamide—Hypoaesthesia—Fluorouracil—stomach cancer	0.000555	0.00448	CcSEcCtD
Enzalutamide—Pharyngitis—Fluorouracil—stomach cancer	0.000554	0.00447	CcSEcCtD
Enzalutamide—AR—digestive system—stomach cancer	0.000553	0.0263	CbGeAlD
Enzalutamide—Musculoskeletal pain—Epirubicin—stomach cancer	0.000547	0.00441	CcSEcCtD
Enzalutamide—Dry skin—Docetaxel—stomach cancer	0.000533	0.0043	CcSEcCtD
Enzalutamide—Angiopathy—Irinotecan—stomach cancer	0.000528	0.00426	CcSEcCtD
Enzalutamide—Nasopharyngitis—Docetaxel—stomach cancer	0.00052	0.0042	CcSEcCtD
Enzalutamide—Dry skin—Capecitabine—stomach cancer	0.000517	0.00417	CcSEcCtD
Enzalutamide—CYP2C19—digestive system—stomach cancer	0.000513	0.0244	CbGeAlD
Enzalutamide—Musculoskeletal pain—Doxorubicin—stomach cancer	0.000506	0.00409	CcSEcCtD
Enzalutamide—Nasopharyngitis—Capecitabine—stomach cancer	0.000504	0.00406	CcSEcCtD
Enzalutamide—Sepsis—Methotrexate—stomach cancer	0.000501	0.00404	CcSEcCtD
Enzalutamide—Muscular weakness—Capecitabine—stomach cancer	0.000497	0.00401	CcSEcCtD
Enzalutamide—Back pain—Irinotecan—stomach cancer	0.00049	0.00396	CcSEcCtD
Enzalutamide—ALB—liver—stomach cancer	0.000474	0.0226	CbGeAlD
Enzalutamide—CYP3A5—pancreas—stomach cancer	0.000473	0.0225	CbGeAlD
Enzalutamide—Neutropenia—Docetaxel—stomach cancer	0.00047	0.00379	CcSEcCtD
Enzalutamide—Sepsis—Epirubicin—stomach cancer	0.000469	0.00379	CcSEcCtD
Enzalutamide—Bronchitis—Capecitabine—stomach cancer	0.000468	0.00378	CcSEcCtD
Enzalutamide—AR—endocrine gland—stomach cancer	0.000457	0.0218	CbGeAlD
Enzalutamide—Vertigo—Irinotecan—stomach cancer	0.000456	0.00367	CcSEcCtD
Enzalutamide—Neutropenia—Capecitabine—stomach cancer	0.000455	0.00367	CcSEcCtD
Enzalutamide—Leukopenia—Irinotecan—stomach cancer	0.000454	0.00366	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000453	0.00365	CcSEcCtD
Enzalutamide—Pneumonia—Docetaxel—stomach cancer	0.000451	0.00364	CcSEcCtD
Enzalutamide—Infestation NOS—Docetaxel—stomach cancer	0.000449	0.00362	CcSEcCtD
Enzalutamide—Infestation—Docetaxel—stomach cancer	0.000449	0.00362	CcSEcCtD
Enzalutamide—Hypertension—Irinotecan—stomach cancer	0.000438	0.00353	CcSEcCtD
Enzalutamide—Pneumonia—Capecitabine—stomach cancer	0.000437	0.00352	CcSEcCtD
Enzalutamide—CYP3A4—hematopoietic system—stomach cancer	0.000436	0.0207	CbGeAlD
Enzalutamide—Leukopenia—Fluorouracil—stomach cancer	0.000435	0.00351	CcSEcCtD
Enzalutamide—Infestation NOS—Capecitabine—stomach cancer	0.000434	0.0035	CcSEcCtD
Enzalutamide—Infestation—Capecitabine—stomach cancer	0.000434	0.0035	CcSEcCtD
Enzalutamide—Sepsis—Doxorubicin—stomach cancer	0.000434	0.0035	CcSEcCtD
Enzalutamide—CYP2D6—hematopoietic system—stomach cancer	0.000429	0.0204	CbGeAlD
Enzalutamide—CYP2C19—endocrine gland—stomach cancer	0.000424	0.0202	CbGeAlD
Enzalutamide—Epistaxis—Docetaxel—stomach cancer	0.000423	0.00341	CcSEcCtD
Enzalutamide—Convulsion—Fluorouracil—stomach cancer	0.000421	0.00339	CcSEcCtD
Enzalutamide—Hot flush—Epirubicin—stomach cancer	0.00042	0.00338	CcSEcCtD
Enzalutamide—Menopausal symptoms—Epirubicin—stomach cancer	0.000416	0.00336	CcSEcCtD
Enzalutamide—Haematuria—Capecitabine—stomach cancer	0.000414	0.00334	CcSEcCtD
Enzalutamide—AR—liver—stomach cancer	0.000412	0.0196	CbGeAlD
Enzalutamide—Infection—Irinotecan—stomach cancer	0.000411	0.00332	CcSEcCtD
Enzalutamide—Epistaxis—Capecitabine—stomach cancer	0.00041	0.0033	CcSEcCtD
Enzalutamide—CYP2B6—lymphoid tissue—stomach cancer	0.000406	0.0193	CbGeAlD
Enzalutamide—Nervous system disorder—Irinotecan—stomach cancer	0.000406	0.00327	CcSEcCtD
Enzalutamide—Thrombocytopenia—Irinotecan—stomach cancer	0.000405	0.00327	CcSEcCtD
Enzalutamide—CYP3A5—digestive system—stomach cancer	0.000404	0.0192	CbGeAlD
Enzalutamide—Rhinitis—Docetaxel—stomach cancer	0.000404	0.00326	CcSEcCtD
Enzalutamide—CYP2B6—digestive system—stomach cancer	0.000401	0.0191	CbGeAlD
Enzalutamide—Hypoaesthesia—Docetaxel—stomach cancer	0.000401	0.00323	CcSEcCtD
Enzalutamide—Pharyngitis—Docetaxel—stomach cancer	0.0004	0.00322	CcSEcCtD
Enzalutamide—Urinary tract disorder—Docetaxel—stomach cancer	0.000398	0.00321	CcSEcCtD
Enzalutamide—CYP2C9—digestive system—stomach cancer	0.000397	0.0189	CbGeAlD
Enzalutamide—Oedema peripheral—Docetaxel—stomach cancer	0.000397	0.0032	CcSEcCtD
Enzalutamide—Connective tissue disorder—Docetaxel—stomach cancer	0.000396	0.00319	CcSEcCtD
Enzalutamide—Urethral disorder—Docetaxel—stomach cancer	0.000395	0.00318	CcSEcCtD
Enzalutamide—Infection—Fluorouracil—stomach cancer	0.000394	0.00318	CcSEcCtD
Enzalutamide—Rhinitis—Capecitabine—stomach cancer	0.000391	0.00315	CcSEcCtD
Enzalutamide—Nervous system disorder—Fluorouracil—stomach cancer	0.000389	0.00313	CcSEcCtD
Enzalutamide—Hot flush—Doxorubicin—stomach cancer	0.000388	0.00313	CcSEcCtD
Enzalutamide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000388	0.00313	CcSEcCtD
Enzalutamide—Hypoaesthesia—Capecitabine—stomach cancer	0.000388	0.00313	CcSEcCtD
Enzalutamide—Pharyngitis—Capecitabine—stomach cancer	0.000387	0.00312	CcSEcCtD
Enzalutamide—Urinary tract disorder—Capecitabine—stomach cancer	0.000385	0.00311	CcSEcCtD
Enzalutamide—Menopausal symptoms—Doxorubicin—stomach cancer	0.000385	0.0031	CcSEcCtD
Enzalutamide—Oedema peripheral—Capecitabine—stomach cancer	0.000384	0.0031	CcSEcCtD
Enzalutamide—Connective tissue disorder—Capecitabine—stomach cancer	0.000383	0.00309	CcSEcCtD
Enzalutamide—Urethral disorder—Capecitabine—stomach cancer	0.000382	0.00308	CcSEcCtD
Enzalutamide—CYP2C19—liver—stomach cancer	0.000382	0.0182	CbGeAlD
Enzalutamide—Insomnia—Irinotecan—stomach cancer	0.000374	0.00302	CcSEcCtD
Enzalutamide—Paraesthesia—Irinotecan—stomach cancer	0.000372	0.003	CcSEcCtD
Enzalutamide—CYP2C8—endocrine gland—stomach cancer	0.00037	0.0176	CbGeAlD
Enzalutamide—Angiopathy—Docetaxel—stomach cancer	0.000365	0.00295	CcSEcCtD
Enzalutamide—ALB—lymph node—stomach cancer	0.000364	0.0173	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000361	0.00291	CcSEcCtD
Enzalutamide—Dry skin—Epirubicin—stomach cancer	0.00036	0.0029	CcSEcCtD
Enzalutamide—Insomnia—Fluorouracil—stomach cancer	0.000358	0.00289	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000357	0.00288	CcSEcCtD
Enzalutamide—Fatigue—Irinotecan—stomach cancer	0.000357	0.00288	CcSEcCtD
Enzalutamide—Paraesthesia—Fluorouracil—stomach cancer	0.000356	0.00287	CcSEcCtD
Enzalutamide—Angiopathy—Capecitabine—stomach cancer	0.000354	0.00285	CcSEcCtD
Enzalutamide—Mental disorder—Docetaxel—stomach cancer	0.000353	0.00285	CcSEcCtD
Enzalutamide—Nasopharyngitis—Epirubicin—stomach cancer	0.000351	0.00283	CcSEcCtD
Enzalutamide—Muscular weakness—Epirubicin—stomach cancer	0.000346	0.00279	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000342	0.00276	CcSEcCtD
Enzalutamide—Mental disorder—Capecitabine—stomach cancer	0.000342	0.00275	CcSEcCtD
Enzalutamide—Back pain—Docetaxel—stomach cancer	0.000339	0.00273	CcSEcCtD
Enzalutamide—Neutropenia—Methotrexate—stomach cancer	0.000339	0.00273	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000337	0.00272	CcSEcCtD
Enzalutamide—CYP3A5—endocrine gland—stomach cancer	0.000334	0.0159	CbGeAlD
Enzalutamide—CYP2C8—liver—stomach cancer	0.000333	0.0159	CbGeAlD
Enzalutamide—Dry skin—Doxorubicin—stomach cancer	0.000333	0.00269	CcSEcCtD
Enzalutamide—CYP2B6—endocrine gland—stomach cancer	0.000332	0.0158	CbGeAlD
Enzalutamide—CYP2C9—endocrine gland—stomach cancer	0.000328	0.0156	CbGeAlD
Enzalutamide—Back pain—Capecitabine—stomach cancer	0.000328	0.00265	CcSEcCtD
Enzalutamide—Bronchitis—Epirubicin—stomach cancer	0.000326	0.00263	CcSEcCtD
Enzalutamide—Pneumonia—Methotrexate—stomach cancer	0.000325	0.00262	CcSEcCtD
Enzalutamide—Nasopharyngitis—Doxorubicin—stomach cancer	0.000325	0.00262	CcSEcCtD
Enzalutamide—Infestation—Methotrexate—stomach cancer	0.000323	0.00261	CcSEcCtD
Enzalutamide—Infestation NOS—Methotrexate—stomach cancer	0.000323	0.00261	CcSEcCtD
Enzalutamide—Muscular weakness—Doxorubicin—stomach cancer	0.00032	0.00258	CcSEcCtD
Enzalutamide—Neutropenia—Epirubicin—stomach cancer	0.000317	0.00256	CcSEcCtD
Enzalutamide—AR—lymph node—stomach cancer	0.000316	0.015	CbGeAlD
Enzalutamide—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000315	0.00254	CcSEcCtD
Enzalutamide—Leukopenia—Docetaxel—stomach cancer	0.000314	0.00253	CcSEcCtD
Enzalutamide—Pollakiuria—Epirubicin—stomach cancer	0.000313	0.00253	CcSEcCtD
Enzalutamide—ABCB1—hematopoietic system—stomach cancer	0.000308	0.0147	CbGeAlD
Enzalutamide—Haematuria—Methotrexate—stomach cancer	0.000308	0.00249	CcSEcCtD
Enzalutamide—Epistaxis—Methotrexate—stomach cancer	0.000305	0.00246	CcSEcCtD
Enzalutamide—Vertigo—Capecitabine—stomach cancer	0.000305	0.00246	CcSEcCtD
Enzalutamide—Pneumonia—Epirubicin—stomach cancer	0.000304	0.00245	CcSEcCtD
Enzalutamide—Leukopenia—Capecitabine—stomach cancer	0.000304	0.00245	CcSEcCtD
Enzalutamide—Convulsion—Docetaxel—stomach cancer	0.000304	0.00245	CcSEcCtD
Enzalutamide—CYP3A4—digestive system—stomach cancer	0.000303	0.0144	CbGeAlD
Enzalutamide—Hypertension—Docetaxel—stomach cancer	0.000303	0.00244	CcSEcCtD
Enzalutamide—Infestation NOS—Epirubicin—stomach cancer	0.000303	0.00244	CcSEcCtD
Enzalutamide—Infestation—Epirubicin—stomach cancer	0.000303	0.00244	CcSEcCtD
Enzalutamide—Bronchitis—Doxorubicin—stomach cancer	0.000302	0.00244	CcSEcCtD
Enzalutamide—CYP3A5—liver—stomach cancer	0.000301	0.0143	CbGeAlD
Enzalutamide—CYP2B6—liver—stomach cancer	0.000299	0.0142	CbGeAlD
Enzalutamide—Arthralgia—Docetaxel—stomach cancer	0.000298	0.00241	CcSEcCtD
Enzalutamide—CYP2D6—digestive system—stomach cancer	0.000298	0.0142	CbGeAlD
Enzalutamide—Asthenia—Irinotecan—stomach cancer	0.000297	0.00239	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000296	0.00239	CcSEcCtD
Enzalutamide—CYP2C9—liver—stomach cancer	0.000296	0.0141	CbGeAlD
Enzalutamide—Neutropenia—Doxorubicin—stomach cancer	0.000294	0.00237	CcSEcCtD
Enzalutamide—Hypertension—Capecitabine—stomach cancer	0.000293	0.00236	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000292	0.00235	CcSEcCtD
Enzalutamide—Pollakiuria—Doxorubicin—stomach cancer	0.00029	0.00234	CcSEcCtD
Enzalutamide—Arthralgia—Capecitabine—stomach cancer	0.000289	0.00233	CcSEcCtD
Enzalutamide—Haematuria—Epirubicin—stomach cancer	0.000288	0.00233	CcSEcCtD
Enzalutamide—Pharyngitis—Methotrexate—stomach cancer	0.000288	0.00232	CcSEcCtD
Enzalutamide—Anxiety—Capecitabine—stomach cancer	0.000288	0.00232	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000287	0.00231	CcSEcCtD
Enzalutamide—Urinary tract disorder—Methotrexate—stomach cancer	0.000287	0.00231	CcSEcCtD
Enzalutamide—Epistaxis—Epirubicin—stomach cancer	0.000285	0.0023	CcSEcCtD
Enzalutamide—Urethral disorder—Methotrexate—stomach cancer	0.000284	0.00229	CcSEcCtD
Enzalutamide—Infection—Docetaxel—stomach cancer	0.000284	0.00229	CcSEcCtD
Enzalutamide—Sinusitis—Epirubicin—stomach cancer	0.000284	0.00229	CcSEcCtD
Enzalutamide—Diarrhoea—Irinotecan—stomach cancer	0.000283	0.00228	CcSEcCtD
Enzalutamide—ABCB1—epithelium—stomach cancer	0.000282	0.0134	CbGeAlD
Enzalutamide—Pneumonia—Doxorubicin—stomach cancer	0.000282	0.00227	CcSEcCtD
Enzalutamide—Nervous system disorder—Docetaxel—stomach cancer	0.000281	0.00226	CcSEcCtD
Enzalutamide—Pruritus—Fluorouracil—stomach cancer	0.00028	0.00226	CcSEcCtD
Enzalutamide—Thrombocytopenia—Docetaxel—stomach cancer	0.00028	0.00226	CcSEcCtD
Enzalutamide—Infestation—Doxorubicin—stomach cancer	0.00028	0.00226	CcSEcCtD
Enzalutamide—Infestation NOS—Doxorubicin—stomach cancer	0.00028	0.00226	CcSEcCtD
Enzalutamide—Skin disorder—Docetaxel—stomach cancer	0.000278	0.00224	CcSEcCtD
Enzalutamide—Infection—Capecitabine—stomach cancer	0.000275	0.00222	CcSEcCtD
Enzalutamide—Dizziness—Irinotecan—stomach cancer	0.000274	0.00221	CcSEcCtD
Enzalutamide—Rhinitis—Epirubicin—stomach cancer	0.000272	0.0022	CcSEcCtD
Enzalutamide—Nervous system disorder—Capecitabine—stomach cancer	0.000272	0.00219	CcSEcCtD
Enzalutamide—Diarrhoea—Fluorouracil—stomach cancer	0.000271	0.00219	CcSEcCtD
Enzalutamide—Thrombocytopenia—Capecitabine—stomach cancer	0.000271	0.00219	CcSEcCtD
Enzalutamide—Hypoaesthesia—Epirubicin—stomach cancer	0.00027	0.00218	CcSEcCtD
Enzalutamide—Pharyngitis—Epirubicin—stomach cancer	0.00027	0.00217	CcSEcCtD
Enzalutamide—Skin disorder—Capecitabine—stomach cancer	0.000269	0.00217	CcSEcCtD
Enzalutamide—Urinary tract disorder—Epirubicin—stomach cancer	0.000268	0.00216	CcSEcCtD
Enzalutamide—Oedema peripheral—Epirubicin—stomach cancer	0.000268	0.00216	CcSEcCtD
Enzalutamide—Haematuria—Doxorubicin—stomach cancer	0.000267	0.00215	CcSEcCtD
Enzalutamide—Connective tissue disorder—Epirubicin—stomach cancer	0.000267	0.00215	CcSEcCtD
Enzalutamide—Urethral disorder—Epirubicin—stomach cancer	0.000266	0.00215	CcSEcCtD
Enzalutamide—Epistaxis—Doxorubicin—stomach cancer	0.000264	0.00213	CcSEcCtD
Enzalutamide—Angiopathy—Methotrexate—stomach cancer	0.000263	0.00212	CcSEcCtD
Enzalutamide—Sinusitis—Doxorubicin—stomach cancer	0.000263	0.00212	CcSEcCtD
Enzalutamide—Dizziness—Fluorouracil—stomach cancer	0.000262	0.00211	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000261	0.0021	CcSEcCtD
Enzalutamide—Headache—Irinotecan—stomach cancer	0.000259	0.00209	CcSEcCtD
Enzalutamide—Insomnia—Docetaxel—stomach cancer	0.000259	0.00209	CcSEcCtD
Enzalutamide—Paraesthesia—Docetaxel—stomach cancer	0.000257	0.00207	CcSEcCtD
Enzalutamide—Mental disorder—Methotrexate—stomach cancer	0.000254	0.00205	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000252	0.00204	CcSEcCtD
Enzalutamide—Rhinitis—Doxorubicin—stomach cancer	0.000252	0.00203	CcSEcCtD
Enzalutamide—ABCB1—pancreas—stomach cancer	0.000251	0.012	CbGeAlD
Enzalutamide—Insomnia—Capecitabine—stomach cancer	0.000251	0.00202	CcSEcCtD
Enzalutamide—CYP3A4—endocrine gland—stomach cancer	0.00025	0.0119	CbGeAlD
Enzalutamide—Hypoaesthesia—Doxorubicin—stomach cancer	0.00025	0.00202	CcSEcCtD
Enzalutamide—Pharyngitis—Doxorubicin—stomach cancer	0.000249	0.00201	CcSEcCtD
Enzalutamide—Paraesthesia—Capecitabine—stomach cancer	0.000249	0.00201	CcSEcCtD
Enzalutamide—Headache—Fluorouracil—stomach cancer	0.000248	0.002	CcSEcCtD
Enzalutamide—Urinary tract disorder—Doxorubicin—stomach cancer	0.000248	0.002	CcSEcCtD
Enzalutamide—Oedema peripheral—Doxorubicin—stomach cancer	0.000248	0.002	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000247	0.00199	CcSEcCtD
Enzalutamide—Connective tissue disorder—Doxorubicin—stomach cancer	0.000247	0.00199	CcSEcCtD
Enzalutamide—Fatigue—Docetaxel—stomach cancer	0.000247	0.00199	CcSEcCtD
Enzalutamide—Angiopathy—Epirubicin—stomach cancer	0.000246	0.00199	CcSEcCtD
Enzalutamide—CYP2D6—endocrine gland—stomach cancer	0.000246	0.0117	CbGeAlD
Enzalutamide—Urethral disorder—Doxorubicin—stomach cancer	0.000246	0.00199	CcSEcCtD
Enzalutamide—Back pain—Methotrexate—stomach cancer	0.000244	0.00197	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000239	0.00193	CcSEcCtD
Enzalutamide—Fatigue—Capecitabine—stomach cancer	0.000239	0.00193	CcSEcCtD
Enzalutamide—Mental disorder—Epirubicin—stomach cancer	0.000238	0.00192	CcSEcCtD
Enzalutamide—Back pain—Epirubicin—stomach cancer	0.000229	0.00184	CcSEcCtD
Enzalutamide—Angiopathy—Doxorubicin—stomach cancer	0.000228	0.00184	CcSEcCtD
Enzalutamide—Vertigo—Methotrexate—stomach cancer	0.000227	0.00183	CcSEcCtD
Enzalutamide—Leukopenia—Methotrexate—stomach cancer	0.000226	0.00182	CcSEcCtD
Enzalutamide—CYP3A4—liver—stomach cancer	0.000226	0.0107	CbGeAlD
Enzalutamide—CYP2D6—liver—stomach cancer	0.000222	0.0106	CbGeAlD
Enzalutamide—Mental disorder—Doxorubicin—stomach cancer	0.00022	0.00178	CcSEcCtD
Enzalutamide—Convulsion—Methotrexate—stomach cancer	0.000219	0.00177	CcSEcCtD
Enzalutamide—ABCB1—lymphoid tissue—stomach cancer	0.000217	0.0103	CbGeAlD
Enzalutamide—Arthralgia—Methotrexate—stomach cancer	0.000215	0.00173	CcSEcCtD
Enzalutamide—ABCB1—digestive system—stomach cancer	0.000214	0.0102	CbGeAlD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000214	0.00172	CcSEcCtD
Enzalutamide—Vertigo—Epirubicin—stomach cancer	0.000212	0.00171	CcSEcCtD
Enzalutamide—Leukopenia—Epirubicin—stomach cancer	0.000212	0.00171	CcSEcCtD
Enzalutamide—Back pain—Doxorubicin—stomach cancer	0.000212	0.00171	CcSEcCtD
Enzalutamide—Asthenia—Docetaxel—stomach cancer	0.000205	0.00166	CcSEcCtD
Enzalutamide—Convulsion—Epirubicin—stomach cancer	0.000205	0.00165	CcSEcCtD
Enzalutamide—Infection—Methotrexate—stomach cancer	0.000205	0.00165	CcSEcCtD
Enzalutamide—Hypertension—Epirubicin—stomach cancer	0.000204	0.00165	CcSEcCtD
Enzalutamide—Pruritus—Docetaxel—stomach cancer	0.000202	0.00163	CcSEcCtD
Enzalutamide—Nervous system disorder—Methotrexate—stomach cancer	0.000202	0.00163	CcSEcCtD
Enzalutamide—Thrombocytopenia—Methotrexate—stomach cancer	0.000202	0.00163	CcSEcCtD
Enzalutamide—Arthralgia—Epirubicin—stomach cancer	0.000201	0.00162	CcSEcCtD
Enzalutamide—Anxiety—Epirubicin—stomach cancer	0.000201	0.00162	CcSEcCtD
Enzalutamide—Skin disorder—Methotrexate—stomach cancer	0.0002	0.00162	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.0002	0.00161	CcSEcCtD
Enzalutamide—Asthenia—Capecitabine—stomach cancer	0.000199	0.0016	CcSEcCtD
Enzalutamide—ABCB1—bone marrow—stomach cancer	0.000198	0.00941	CbGeAlD
Enzalutamide—Vertigo—Doxorubicin—stomach cancer	0.000197	0.00159	CcSEcCtD
Enzalutamide—Pruritus—Capecitabine—stomach cancer	0.000196	0.00158	CcSEcCtD
Enzalutamide—Leukopenia—Doxorubicin—stomach cancer	0.000196	0.00158	CcSEcCtD
Enzalutamide—Diarrhoea—Docetaxel—stomach cancer	0.000196	0.00158	CcSEcCtD
Enzalutamide—Infection—Epirubicin—stomach cancer	0.000192	0.00155	CcSEcCtD
Enzalutamide—Convulsion—Doxorubicin—stomach cancer	0.00019	0.00153	CcSEcCtD
Enzalutamide—Diarrhoea—Capecitabine—stomach cancer	0.00019	0.00153	CcSEcCtD
Enzalutamide—Nervous system disorder—Epirubicin—stomach cancer	0.000189	0.00153	CcSEcCtD
Enzalutamide—Dizziness—Docetaxel—stomach cancer	0.000189	0.00153	CcSEcCtD
Enzalutamide—Thrombocytopenia—Epirubicin—stomach cancer	0.000189	0.00152	CcSEcCtD
Enzalutamide—Hypertension—Doxorubicin—stomach cancer	0.000189	0.00152	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000188	0.00152	CcSEcCtD
Enzalutamide—Skin disorder—Epirubicin—stomach cancer	0.000187	0.00151	CcSEcCtD
Enzalutamide—Insomnia—Methotrexate—stomach cancer	0.000186	0.0015	CcSEcCtD
Enzalutamide—Arthralgia—Doxorubicin—stomach cancer	0.000186	0.0015	CcSEcCtD
Enzalutamide—Anxiety—Doxorubicin—stomach cancer	0.000186	0.0015	CcSEcCtD
Enzalutamide—Paraesthesia—Methotrexate—stomach cancer	0.000185	0.00149	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000185	0.00149	CcSEcCtD
Enzalutamide—Dizziness—Capecitabine—stomach cancer	0.000183	0.00148	CcSEcCtD
Enzalutamide—Headache—Docetaxel—stomach cancer	0.000179	0.00145	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000178	0.00144	CcSEcCtD
Enzalutamide—Fatigue—Methotrexate—stomach cancer	0.000178	0.00143	CcSEcCtD
Enzalutamide—Infection—Doxorubicin—stomach cancer	0.000177	0.00143	CcSEcCtD
Enzalutamide—ABCB1—endocrine gland—stomach cancer	0.000177	0.00844	CbGeAlD
Enzalutamide—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000176	0.00142	CcSEcCtD
Enzalutamide—Nervous system disorder—Doxorubicin—stomach cancer	0.000175	0.00141	CcSEcCtD
Enzalutamide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000175	0.00141	CcSEcCtD
Enzalutamide—Insomnia—Epirubicin—stomach cancer	0.000175	0.00141	CcSEcCtD
Enzalutamide—Headache—Capecitabine—stomach cancer	0.000174	0.0014	CcSEcCtD
Enzalutamide—Skin disorder—Doxorubicin—stomach cancer	0.000173	0.0014	CcSEcCtD
Enzalutamide—Paraesthesia—Epirubicin—stomach cancer	0.000173	0.0014	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000167	0.00134	CcSEcCtD
Enzalutamide—Fatigue—Epirubicin—stomach cancer	0.000166	0.00134	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000163	0.00131	CcSEcCtD
Enzalutamide—Insomnia—Doxorubicin—stomach cancer	0.000161	0.0013	CcSEcCtD
Enzalutamide—Paraesthesia—Doxorubicin—stomach cancer	0.00016	0.00129	CcSEcCtD
Enzalutamide—ABCB1—liver—stomach cancer	0.00016	0.00761	CbGeAlD
Enzalutamide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000154	0.00124	CcSEcCtD
Enzalutamide—Fatigue—Doxorubicin—stomach cancer	0.000154	0.00124	CcSEcCtD
Enzalutamide—Asthenia—Methotrexate—stomach cancer	0.000148	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Methotrexate—stomach cancer	0.000146	0.00118	CcSEcCtD
Enzalutamide—Diarrhoea—Methotrexate—stomach cancer	0.000141	0.00114	CcSEcCtD
Enzalutamide—Asthenia—Epirubicin—stomach cancer	0.000138	0.00112	CcSEcCtD
Enzalutamide—Pruritus—Epirubicin—stomach cancer	0.000137	0.0011	CcSEcCtD
Enzalutamide—Dizziness—Methotrexate—stomach cancer	0.000136	0.0011	CcSEcCtD
Enzalutamide—Diarrhoea—Epirubicin—stomach cancer	0.000132	0.00106	CcSEcCtD
Enzalutamide—Headache—Methotrexate—stomach cancer	0.000129	0.00104	CcSEcCtD
Enzalutamide—Asthenia—Doxorubicin—stomach cancer	0.000128	0.00103	CcSEcCtD
Enzalutamide—Dizziness—Epirubicin—stomach cancer	0.000128	0.00103	CcSEcCtD
Enzalutamide—Pruritus—Doxorubicin—stomach cancer	0.000126	0.00102	CcSEcCtD
Enzalutamide—ABCB1—lymph node—stomach cancer	0.000123	0.00583	CbGeAlD
Enzalutamide—Diarrhoea—Doxorubicin—stomach cancer	0.000122	0.000985	CcSEcCtD
Enzalutamide—Headache—Epirubicin—stomach cancer	0.000121	0.000975	CcSEcCtD
Enzalutamide—Dizziness—Doxorubicin—stomach cancer	0.000118	0.000952	CcSEcCtD
Enzalutamide—Headache—Doxorubicin—stomach cancer	0.000112	0.000902	CcSEcCtD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.5e-05	0.0002	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTT1—stomach cancer	1.5e-05	0.000199	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RORA—stomach cancer	1.49e-05	0.000199	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALOX5—stomach cancer	1.49e-05	0.000199	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ALOX5—stomach cancer	1.48e-05	0.000197	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP2A6—stomach cancer	1.48e-05	0.000197	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—AKR1C3—stomach cancer	1.47e-05	0.000196	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.47e-05	0.000196	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—DPYD—stomach cancer	1.47e-05	0.000195	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—SERPINE1—stomach cancer	1.47e-05	0.000195	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.46e-05	0.000195	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—DPYD—stomach cancer	1.46e-05	0.000194	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—AKR1C3—stomach cancer	1.44e-05	0.000192	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ENO1—stomach cancer	1.44e-05	0.000191	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALDOB—stomach cancer	1.43e-05	0.000191	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	1.43e-05	0.00019	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—SREBF2—stomach cancer	1.42e-05	0.000189	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—SREBF2—stomach cancer	1.41e-05	0.000188	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RORA—stomach cancer	1.41e-05	0.000187	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ENO1—stomach cancer	1.4e-05	0.000187	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALDOB—stomach cancer	1.4e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NDUFA2—stomach cancer	1.39e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FBP1—stomach cancer	1.39e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA1—stomach cancer	1.39e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CKB—stomach cancer	1.39e-05	0.000186	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RORA—stomach cancer	1.39e-05	0.000186	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	1.36e-05	0.000182	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.35e-05	0.00018	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.35e-05	0.000179	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.34e-05	0.000179	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALOX5—stomach cancer	1.33e-05	0.000177	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.33e-05	0.000177	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.32e-05	0.000176	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALDOB—stomach cancer	1.32e-05	0.000175	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLIN2—stomach cancer	1.31e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—DPYD—stomach cancer	1.31e-05	0.000174	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—SERPINE1—stomach cancer	1.31e-05	0.000174	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALDOB—stomach cancer	1.31e-05	0.000174	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALOX5—stomach cancer	1.3e-05	0.000173	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.3e-05	0.000173	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTT1—stomach cancer	1.3e-05	0.000173	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTT1—stomach cancer	1.29e-05	0.000172	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP2A6—stomach cancer	1.28e-05	0.000171	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—DPYD—stomach cancer	1.28e-05	0.00017	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP2A6—stomach cancer	1.27e-05	0.00017	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA2—stomach cancer	1.27e-05	0.00017	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CD44—stomach cancer	1.27e-05	0.00017	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—RHOA—stomach cancer	1.26e-05	0.000168	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.25e-05	0.000166	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—NOS3—stomach cancer	1.25e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—AKR1C3—stomach cancer	1.25e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CD44—stomach cancer	1.24e-05	0.000166	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NT5E—stomach cancer	1.24e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PGAM1—stomach cancer	1.24e-05	0.000165	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—AKR1C3—stomach cancer	1.24e-05	0.000165	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	1.23e-05	0.000164	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	1.23e-05	0.000164	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALOX5—stomach cancer	1.22e-05	0.000163	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ENO1—stomach cancer	1.22e-05	0.000162	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALOX5—stomach cancer	1.21e-05	0.000162	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ENO1—stomach cancer	1.21e-05	0.000161	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—DPYD—stomach cancer	1.2e-05	0.00016	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.2e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—DPYD—stomach cancer	1.19e-05	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.19e-05	0.000158	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDH7A1—stomach cancer	1.18e-05	0.000158	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PLCE1—stomach cancer	1.18e-05	0.000158	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTT1—stomach cancer	1.16e-05	0.000154	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP2A6—stomach cancer	1.14e-05	0.000152	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—UMPS—stomach cancer	1.14e-05	0.000151	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTT1—stomach cancer	1.13e-05	0.000151	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP2A6—stomach cancer	1.12e-05	0.000149	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—AKR1C3—stomach cancer	1.11e-05	0.000148	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—AKR1C3—stomach cancer	1.09e-05	0.000145	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ENO1—stomach cancer	1.08e-05	0.000145	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPP2R1A—stomach cancer	1.08e-05	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.08e-05	0.000144	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CD44—stomach cancer	1.08e-05	0.000144	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CD44—stomach cancer	1.07e-05	0.000143	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.07e-05	0.000142	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTT1—stomach cancer	1.06e-05	0.000142	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTP1—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ENO1—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPP2R1A—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ECHS1—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PDHA1—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTT1—stomach cancer	1.06e-05	0.000141	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP2A6—stomach cancer	1.05e-05	0.00014	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—HMOX1—stomach cancer	1.05e-05	0.00014	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.05e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP2A6—stomach cancer	1.04e-05	0.000139	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.04e-05	0.000139	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTP1—stomach cancer	1.04e-05	0.000138	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000136	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—HMOX1—stomach cancer	1.02e-05	0.000136	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—AKR1C3—stomach cancer	1.02e-05	0.000135	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ENO1—stomach cancer	9.98e-06	0.000133	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FADS1—stomach cancer	9.93e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMP—stomach cancer	9.93e-06	0.000132	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	9.9e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ENO1—stomach cancer	9.89e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TYMS—stomach cancer	9.87e-06	0.000132	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GSTM1—stomach cancer	9.76e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	9.73e-06	0.00013	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TYMS—stomach cancer	9.65e-06	0.000129	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CD44—stomach cancer	9.62e-06	0.000128	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MAPK3—stomach cancer	9.54e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GSTM1—stomach cancer	9.54e-06	0.000127	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CD44—stomach cancer	9.39e-06	0.000125	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	9.34e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—SREBF2—stomach cancer	9.3e-06	0.000124	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—stomach cancer	9.28e-06	0.000124	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RORA—stomach cancer	9.19e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ERCC2—stomach cancer	9.18e-06	0.000122	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPP2R1A—stomach cancer	9.17e-06	0.000122	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPP2R1A—stomach cancer	9.11e-06	0.000121	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—VEGFA—stomach cancer	9e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTP1—stomach cancer	8.99e-06	0.00012	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ERCC2—stomach cancer	8.97e-06	0.000119	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTP1—stomach cancer	8.94e-06	0.000119	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—HMOX1—stomach cancer	8.87e-06	0.000118	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CD44—stomach cancer	8.85e-06	0.000118	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—HMOX1—stomach cancer	8.82e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CD44—stomach cancer	8.77e-06	0.000117	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—stomach cancer	8.62e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALDOB—stomach cancer	8.61e-06	0.000115	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	8.51e-06	0.000113	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK3—stomach cancer	8.51e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—stomach cancer	8.43e-06	0.000112	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TYMS—stomach cancer	8.36e-06	0.000111	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TYMS—stomach cancer	8.31e-06	0.000111	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GSTM1—stomach cancer	8.26e-06	0.00011	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GSTM1—stomach cancer	8.22e-06	0.000109	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPP2R1A—stomach cancer	8.18e-06	0.000109	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—MAPK1—stomach cancer	8.1e-06	0.000108	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTP1—stomach cancer	8.03e-06	0.000107	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALOX5—stomach cancer	8e-06	0.000107	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPP2R1A—stomach cancer	7.99e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CAV1—stomach cancer	7.96e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—APOA1—stomach cancer	7.94e-06	0.000106	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—HMOX1—stomach cancer	7.91e-06	0.000105	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—DPYD—stomach cancer	7.87e-06	0.000105	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTP1—stomach cancer	7.83e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CAV1—stomach cancer	7.78e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ERCC2—stomach cancer	7.77e-06	0.000103	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—APOA1—stomach cancer	7.76e-06	0.000103	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—HMOX1—stomach cancer	7.72e-06	0.000103	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ERCC2—stomach cancer	7.72e-06	0.000103	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—KRAS—stomach cancer	7.65e-06	0.000102	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPP2R1A—stomach cancer	7.52e-06	0.0001	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TYMS—stomach cancer	7.46e-06	9.94e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPP2R1A—stomach cancer	7.46e-06	9.94e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTP1—stomach cancer	7.38e-06	9.83e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GSTM1—stomach cancer	7.37e-06	9.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTP1—stomach cancer	7.32e-06	9.75e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—stomach cancer	7.3e-06	9.73e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TYMS—stomach cancer	7.28e-06	9.7e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—HMOX1—stomach cancer	7.28e-06	9.7e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—stomach cancer	7.26e-06	9.67e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—HMOX1—stomach cancer	7.22e-06	9.61e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GSTM1—stomach cancer	7.2e-06	9.59e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—PIK3CA—stomach cancer	7.03e-06	9.36e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PPARG—stomach cancer	6.99e-06	9.32e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTT1—stomach cancer	6.96e-06	9.27e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ERCC2—stomach cancer	6.93e-06	9.24e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP2A6—stomach cancer	6.88e-06	9.17e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TYMS—stomach cancer	6.86e-06	9.14e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PPARG—stomach cancer	6.84e-06	9.11e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TYMS—stomach cancer	6.8e-06	9.06e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TP53—stomach cancer	6.8e-06	9.06e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GSTM1—stomach cancer	6.78e-06	9.03e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ERCC2—stomach cancer	6.77e-06	9.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CAV1—stomach cancer	6.74e-06	8.97e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GSTM1—stomach cancer	6.72e-06	8.96e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—APOA1—stomach cancer	6.72e-06	8.95e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CAV1—stomach cancer	6.7e-06	8.92e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—AKR1C3—stomach cancer	6.69e-06	8.92e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—APOA1—stomach cancer	6.68e-06	8.9e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO1—stomach cancer	6.52e-06	8.69e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—stomach cancer	6.52e-06	8.68e-05	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—HRAS—stomach cancer	6.5e-06	8.66e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.43e-06	8.57e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.4e-06	8.52e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ERCC2—stomach cancer	6.38e-06	8.49e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—stomach cancer	6.36e-06	8.47e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ERCC2—stomach cancer	6.32e-06	8.42e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ALB—stomach cancer	6.29e-06	8.38e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ALB—stomach cancer	6.15e-06	8.19e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—NOS3—stomach cancer	6.02e-06	8.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CAV1—stomach cancer	6.01e-06	8.01e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—APOA1—stomach cancer	6e-06	7.99e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—stomach cancer	5.99e-06	7.98e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—stomach cancer	5.94e-06	7.92e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PPARG—stomach cancer	5.92e-06	7.89e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PPARG—stomach cancer	5.89e-06	7.84e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—NOS3—stomach cancer	5.88e-06	7.83e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CAV1—stomach cancer	5.87e-06	7.82e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—APOA1—stomach cancer	5.85e-06	7.8e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CD44—stomach cancer	5.79e-06	7.71e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.74e-06	7.65e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CAV1—stomach cancer	5.53e-06	7.36e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—APOA1—stomach cancer	5.52e-06	7.35e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PTGS2—stomach cancer	5.5e-06	7.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CAV1—stomach cancer	5.48e-06	7.3e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—APOA1—stomach cancer	5.47e-06	7.28e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PTGS2—stomach cancer	5.38e-06	7.16e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ALB—stomach cancer	5.32e-06	7.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PPARG—stomach cancer	5.29e-06	7.04e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	5.24e-06	6.98e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PPARG—stomach cancer	5.16e-06	6.87e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—NOS3—stomach cancer	5.09e-06	6.78e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—NOS3—stomach cancer	5.06e-06	6.74e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPP2R1A—stomach cancer	4.92e-06	6.55e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PPARG—stomach cancer	4.86e-06	6.47e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTP1—stomach cancer	4.83e-06	6.43e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PPARG—stomach cancer	4.82e-06	6.42e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—HMOX1—stomach cancer	4.76e-06	6.34e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ALB—stomach cancer	4.75e-06	6.33e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PTGS2—stomach cancer	4.66e-06	6.2e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ALB—stomach cancer	4.64e-06	6.18e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PTGS2—stomach cancer	4.63e-06	6.17e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—NOS3—stomach cancer	4.55e-06	6.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TYMS—stomach cancer	4.49e-06	5.98e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—NOS3—stomach cancer	4.44e-06	5.91e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GSTM1—stomach cancer	4.43e-06	5.91e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ALB—stomach cancer	4.37e-06	5.82e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ALB—stomach cancer	4.33e-06	5.77e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—NOS3—stomach cancer	4.18e-06	5.57e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ERCC2—stomach cancer	4.17e-06	5.55e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PTGS2—stomach cancer	4.16e-06	5.54e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—NOS3—stomach cancer	4.14e-06	5.52e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PTGS2—stomach cancer	4.06e-06	5.4e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—stomach cancer	3.92e-06	5.22e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PTGS2—stomach cancer	3.82e-06	5.09e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PTGS2—stomach cancer	3.79e-06	5.05e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CAV1—stomach cancer	3.62e-06	4.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—APOA1—stomach cancer	3.61e-06	4.8e-05	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PIK3CA—stomach cancer	3.38e-06	4.51e-05	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PIK3CA—stomach cancer	3.31e-06	4.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PPARG—stomach cancer	3.18e-06	4.23e-05	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PIK3CA—stomach cancer	2.87e-06	3.82e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ALB—stomach cancer	2.86e-06	3.81e-05	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PIK3CA—stomach cancer	2.85e-06	3.8e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—NOS3—stomach cancer	2.73e-06	3.64e-05	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.56e-06	3.41e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PTGS2—stomach cancer	2.5e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PIK3CA—stomach cancer	2.5e-06	3.33e-05	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PIK3CA—stomach cancer	2.35e-06	3.13e-05	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PIK3CA—stomach cancer	2.33e-06	3.11e-05	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PIK3CA—stomach cancer	1.54e-06	2.05e-05	CbGpPWpGaD
